These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 38514609)

  • 1. Immunization with V987H-stabilized Spike glycoprotein protects K18-hACE2 mice and golden Syrian hamsters upon SARS-CoV-2 infection.
    Ávila-Nieto C; Vergara-Alert J; Amengual-Rigo P; Ainsua-Enrich E; Brustolin M; Rodríguez de la Concepción ML; Pedreño-Lopez N; Rodon J; Urrea V; Pradenas E; Marfil S; Ballana E; Riveira-Muñoz E; Pérez M; Roca N; Tarrés-Freixas F; Cantero G; Pons-Grífols A; Rovirosa C; Aguilar-Gurrieri C; Ortiz R; Barajas A; Trinité B; Lepore R; Muñoz-Basagoiti J; Perez-Zsolt D; Izquierdo-Useros N; Valencia A; Blanco J; Guallar V; Clotet B; Segalés J; Carrillo J
    Nat Commun; 2024 Mar; 15(1):2349. PubMed ID: 38514609
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel Spike-stabilized trimers with improved production protect K18-hACE2 mice and golden Syrian hamsters from the highly pathogenic SARS-CoV-2 Beta variant.
    Ávila-Nieto C; Vergara-Alert J; Amengual-Rigo P; Ainsua-Enrich E; Brustolin M; Rodríguez de la Concepción ML; Pedreño-Lopez N; Rodon J; Urrea V; Pradenas E; Marfil S; Ballana E; Riveira-Muñoz E; Pérez M; Roca N; Tarrés-Freixas F; Carabelli J; Cantero G; Pons-Grífols A; Rovirosa C; Aguilar-Gurrieri C; Ortiz R; Barajas A; Trinité B; Lepore R; Muñoz-Basagoiti J; Perez-Zsolt D; Izquierdo-Useros N; Valencia A; Blanco J; Clotet B; Guallar V; Segalés J; Carrillo J
    Front Immunol; 2023; 14():1291972. PubMed ID: 38124756
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Methyltransferase-Defective Vesicular Stomatitis Virus-Based SARS-CoV-2 Vaccine Candidate Provides Complete Protection against SARS-CoV-2 Infection in Hamsters.
    Lu M; Zhang Y; Dravid P; Li A; Zeng C; Kc M; Trivedi S; Sharma H; Chaiwatpongsakorn S; Zani A; Kenney A; Cai C; Ye C; Liang X; Qiu J; Martinez-Sobrido L; Yount JS; Boyaka PN; Liu SL; Peeples ME; Kapoor A; Li J
    J Virol; 2021 Sep; 95(20):e0059221. PubMed ID: 34379509
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RBD-VLP Vaccines Adjuvanted with Alum or SWE Protect K18-hACE2 Mice against SARS-CoV-2 VOC Challenge.
    Wong TY; Russ BP; Lee KS; Miller OA; Kang J; Cooper M; Winters MT; Rodriguez-Aponte SA; Dalvie NC; Johnston RS; Rader NA; Wong ZY; Cyphert HA; Martinez I; Shaligram U; Batwal S; Lothe R; Chandrasekaran R; Nagar G; Rajurkar M; Rao H; Bevere JR; Barbier M; Love JC; Damron FH
    mSphere; 2022 Aug; 7(4):e0024322. PubMed ID: 35968964
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Single MVA-SARS-2-ST/N Vaccination Rapidly Protects K18-hACE2 Mice against a Lethal SARS-CoV-2 Challenge Infection.
    Clever S; Limpinsel L; Meyer Zu Natrup C; Schünemann LM; Beythien G; Rosiak M; Hülskötter K; Gregor KM; Tuchel T; Kalodimou G; Freudenstein A; Kumar S; Baumgärtner W; Sutter G; Tscherne A; Volz A
    Viruses; 2024 Mar; 16(3):. PubMed ID: 38543782
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunization with Recombinant Accessory Protein-Deficient SARS-CoV-2 Protects against Lethal Challenge and Viral Transmission.
    Ye C; Park JG; Chiem K; Dravid P; Allué-Guardia A; Garcia-Vilanova A; Pino Tamayo P; Shivanna V; Kapoor A; Walter MR; Kobie JJ; Plemper RK; Torrelles JB; Martinez-Sobrido L
    Microbiol Spectr; 2023 Jun; 11(3):e0065323. PubMed ID: 37191507
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intranasal VLP-RBD vaccine adjuvanted with BECC470 confers immunity against Delta SARS-CoV-2 challenge in K18-hACE2-mice.
    Lee KS; Rader NA; Miller-Stump OA; Cooper M; Wong TY; Shahrier Amin M; Barbier M; Bevere JR; Ernst RK; Heath Damron F
    Vaccine; 2023 Jul; 41(34):5003-5017. PubMed ID: 37407405
    [TBL] [Abstract][Full Text] [Related]  

  • 8. One dose of COVID-19 nanoparticle vaccine REVC-128 protects against SARS-CoV-2 challenge at two weeks post-immunization.
    Gu M; Torres JL; Li Y; Van Ry A; Greenhouse J; Wallace S; Chiang CI; Pessaint L; Jackson AM; Porto M; Kar S; Li Y; Ward AB; Wang Y
    Emerg Microbes Infect; 2021 Dec; 10(1):2016-2029. PubMed ID: 34651563
    [No Abstract]   [Full Text] [Related]  

  • 9. SARS-CoV-2 prefusion spike protein stabilized by six rather than two prolines is more potent for inducing antibodies that neutralize viral variants of concern.
    Lu M; Chamblee M; Zhang Y; Ye C; Dravid P; Park JG; Mahesh KC; Trivedi S; Murthy S; Sharma H; Cassady C; Chaiwatpongsakorn S; Liang X; Yount JS; Boyaka PN; Peeples ME; Martinez-Sobrido L; Kapoor A; Li J
    Proc Natl Acad Sci U S A; 2022 Aug; 119(35):e2110105119. PubMed ID: 35994646
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A safe and highly efficacious measles virus-based vaccine expressing SARS-CoV-2 stabilized prefusion spike.
    Lu M; Dravid P; Zhang Y; Trivedi S; Li A; Harder O; Kc M; Chaiwatpongsakorn S; Zani A; Kenney A; Zeng C; Cai C; Ye C; Liang X; Shimamura M; Liu SL; Mejias A; Ramilo O; Boyaka PN; Qiu J; Martinez-Sobrido L; Yount JS; Peeples ME; Kapoor A; Niewiesk S; Li J
    Proc Natl Acad Sci U S A; 2021 Mar; 118(12):. PubMed ID: 33688034
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Glycosylated RBD Protein Induces Enhanced Neutralizing Antibodies against Omicron and Other Variants with Improved Protection against SARS-CoV-2 Infection.
    Shi J; Zheng J; Tai W; Verma AK; Zhang X; Geng Q; Wang G; Guan X; Malisheni MM; Odle AE; Zhang W; Li F; Perlman S; Du L
    J Virol; 2022 Sep; 96(17):e0011822. PubMed ID: 35972290
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A single intranasal dose of a live-attenuated parainfluenza virus-vectored SARS-CoV-2 vaccine is protective in hamsters.
    Liu X; Luongo C; Matsuoka Y; Park HS; Santos C; Yang L; Moore IN; Afroz S; Johnson RF; Lafont BAP; Martens C; Best SM; Munster VJ; Hollý J; Yewdell JW; Le Nouën C; Munir S; Buchholz UJ
    Proc Natl Acad Sci U S A; 2021 Dec; 118(50):. PubMed ID: 34876520
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Newcastle Disease Virus (NDV)-based vaccine candidate against SARS-CoV-2 Omicron by intranasal immunization.
    Zhang QY; Zhang HQ; Zhang YN; Zhang ZR; Li XD; Hao MC; Zhang Y; Li JQ; Hu YY; Chen XL; Wang J; Shi YJ; Deng CL; Chen JJ; Ye HQ; Zhang B
    Antiviral Res; 2023 Dec; 220():105757. PubMed ID: 37984567
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neutralizing Monoclonal Antibodies That Target the Spike Receptor Binding Domain Confer Fc Receptor-Independent Protection against SARS-CoV-2 Infection in Syrian Hamsters.
    Su W; Sia SF; Schmitz AJ; Bricker TL; Starr TN; Greaney AJ; Turner JS; Mohammed BM; Liu Z; Choy KT; Darling TL; Joshi A; Cheng KM; Wong AYL; Harastani HH; Nicholls JM; Whelan SPJ; Bloom JD; Yen HL; Ellebedy AH; Boon ACM
    mBio; 2021 Oct; 12(5):e0239521. PubMed ID: 34517754
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A variant-proof SARS-CoV-2 vaccine targeting HR1 domain in S2 subunit of spike protein.
    Pang W; Lu Y; Zhao YB; Shen F; Fan CF; Wang Q; He WQ; He XY; Li ZK; Chen TT; Yang CX; Li YZ; Xiao SX; Zhao ZJ; Huang XS; Luo RH; Yang LM; Zhang M; Dong XQ; Li MH; Feng XL; Zhou QC; Qu W; Jiang S; Ouyang S; Zheng YT
    Cell Res; 2022 Dec; 32(12):1068-1085. PubMed ID: 36357786
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vaccine-associated respiratory pathology correlates with viral clearance and protective immunity after immunization with self-amplifying RNA expressing the spike (S) protein of SARS-CoV-2 in mouse models.
    Kachko A; Selvaraj P; Liu S; Kim J; Rotstein D; Stauft CB; Chabot S; Rajasagi N; Zhao Y; Wang T; Major M
    Vaccine; 2024 Jan; 42(3):608-619. PubMed ID: 38142216
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mucosal immunization with ChAd-SARS-CoV-2-S prevents sequential transmission of SARS-CoV-2 to unvaccinated hamsters.
    Darling TL; Harastani HH; Joshi A; Bricker TL; Soudani N; Seehra K; Hassan AO; Diamond MS; Boon ACM
    Sci Adv; 2024 Aug; 10(31):eadp1290. PubMed ID: 39083604
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MVA-CoV2-S Vaccine Candidate Neutralizes Distinct Variants of Concern and Protects Against SARS-CoV-2 Infection in Hamsters.
    Boudewijns R; Pérez P; Lázaro-Frías A; Van Looveren D; Vercruysse T; Thibaut HJ; Weynand B; Coelmont L; Neyts J; Astorgano D; Montenegro D; Puentes E; Rodríguez E; Dallmeier K; Esteban M; García-Arriaza J
    Front Immunol; 2022; 13():845969. PubMed ID: 35371064
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of the SARS-CoV-2 BA.5.5 and BQ.1.1 Omicron variants in mice and hamsters.
    Case JB; Scheaffer SM; Darling TL; Bricker TL; Adams LJ; Harastani HH; Trende R; Sanapala S; Fremont DH; Boon ACM; Diamond MS
    J Virol; 2023 Sep; 97(9):e0062823. PubMed ID: 37676002
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inactivated whole virion vaccine protects K18-hACE2 Tg mice against the Omicron SARS-CoV-2 variant via cross-reactive T cells and nonneutralizing antibody responses.
    Kruglov AA; Bondareva MA; Gogoleva VS; Semin IK; Astrakhantseva IV; Zvartsev R; Lunin AS; Apolokhov VD; Shustova EY; Volok VP; Ustyugov AA; Ishmukhametov AA; Nedospasov SA; Kozlovskaya LI; Drutskaya MS
    Eur J Immunol; 2024 Mar; 54(3):e2350664. PubMed ID: 38088236
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.